Clinical trials. A pending subject

被引:2
|
作者
Gil-Extremera, B. [1 ]
Jimenez-Lopez, P. [1 ]
Mediavilla-Garcia, J. D. [1 ]
机构
[1] Univ Granada, Dept Med, Granada, Spain
来源
REVISTA CLINICA ESPANOLA | 2018年 / 218卷 / 03期
关键词
Clinical trial; Hypertension; Diabetes; Dyslipidaemia; HIGH-RISK PATIENTS; SYSTOLIC HYPERTENSION; EFFICACY; EVENTS; SAFETY; TELMISARTAN; PREVENTION; DEMENTIA; OUTCOMES; OLDER;
D O I
10.1016/j.rce.2017.06.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clinical trials are essential tools for the progress of clinical medicine in its diagnostic and therapeutic aspects. Since the first trial in 1948, which related tobacco use with lung cancer, there have been more than 150,000 clinical trials to date in various areas (paediatrics, cardiology, oncology, endocrinology, etc.). This article highlights the importance for all physicians to participate, over the course of their professional career, in a clinical trial, due to the inherent benefits for patients, the progress of medicine and for curricular prestige. The authors have created a synthesis of their experience with clinical trials on hypertension, diabetes, dyslipidaemia and ischaemic heart disease over the course of almost 3 decades. Furthermore, a brief reference has been made to the characteristics of a phase I unit, as well as to a number of research studies currently underway. (C) 2017 Elsevier Espana, S.L.U. and Sociedad Espanola de Medicina Interna (SEMI). All rights reserved.
引用
收藏
页码:137 / 141
页数:5
相关论文
共 50 条
  • [21] Update of alendronate safety in clinical trials.
    Leung, A
    Heyden, N
    Czachur, M
    Gilbert, J
    Daifotis, A
    Yates, AJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S525 - S525
  • [22] Establishing digital biomarkers for clinical trials.
    Thomas, Neil
    Mattek, Nora
    Riley, Thomas
    Witter, Phelps
    Reynolds, Christina
    Austin, Johanna
    Sharma, Nicole
    Marcoe, Jennifer
    Kaye, Jeffrey
    NEUROLOGY, 2018, 90
  • [23] Qualifying sites for oncology clinical trials.
    Kurbegov, Dax
    Kim, Edward S.
    Hurley, Patricia A.
    Waterhouse, David Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [24] Experimental analytical trials. The clinical trial
    Conejero, Antonio Martin
    Garcia, Marcos Alonso
    ANGIOLOGIA, 2024, 76 (01): : 30 - 37
  • [25] Patient and clinical trials. Are they involved enough?
    Geissler, J.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S71 - S71
  • [26] Quality of life assessment in clinical trials.
    Cramer, JA
    EPILEPSIA, 1999, 40 : 214 - 214
  • [27] Diversity in multiple myeloma clinical trials.
    Duma, Narjust
    Velez, Miguel Gonzalez
    Vera-Aguilera, Jesus
    Parrondo, Richardo
    Mariotti, Veronica
    Paludo, Jonas
    Wang, Yucai
    Go, Ronald
    Adjei, Alex
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 68 - 68
  • [28] Good clinical practices in monitoring antihypertensive clinical trials.
    Jett, CM
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 115A - 115A
  • [29] Measurement of somatic neuropathy for clinical practice and clinical trials.
    Scott L.V.
    Tesfaye S.
    Current Diabetes Reports, 2001, 1 (3) : 208 - 215
  • [30] Monitoring of clinical trials. Establishment, measures and consequences
    Pritsch, M
    Unnebrink, K
    MEDIZINISCHE KLINIK, 2000, 95 : 72 - 76